about
Suppression of lung tumorigenesis by leucine zipper/EF hand-containing transmembrane-1Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesionsSerum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic responseHyperosmotic stress stimulates promoter activity and regulates cellular utilization of the serum- and glucocorticoid-inducible protein kinase (Sgk) by a p38 MAPK-dependent pathway.Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage.Intramolecular and intermolecular interactions of protein kinase B define its activation in vivoModulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTCIdentification of AMPK activator from twelve pure compounds isolated from Aralia Taibaiensis: implication in antihyperglycemic and hypolipidemic activities.Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase--significance for diabetes and cancer.Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effectsExpression of PGC1α in glioblastoma multiforme patients.Neuroprotection by acetyl-11-keto-β-Boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathwayMultiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer.PKB binding proteins. Getting in on the Akt.Molecular cloning and expression analysis of pig lymphocyte activation gene-3 (LAG-3; CD223).Alteration of Phospholipids during the Mitophagic Process in Lung Cancer Cells.mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulin-mediated intracellular signaling cascade.Prevention of TNF-induced necrotic cell death by rottlerin through a Nox1 NADPH oxidase.Silver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells.Overexpression of ryanodine receptor type 1 enhances mitochondrial fragmentation and Ca2+-induced ATP production in cardiac H9c2 myoblastsThe role of the transcription factor ETV5 in insulin exocytosis.Coupling of LETM1 up-regulation with oxidative phosphorylation and platelet-derived growth factor receptor signaling via YAP1 transactivationDihydroergotamine Tartrate Induces Lung Cancer Cell Death through Apoptosis and Mitophagy.Involvement of Src and the actin cytoskeleton in the antitumorigenic action of adenosine dialdehyde.Carboxyl-terminal modulator protein induces apoptosis by regulating mitochondrial function in lung cancer cells.Src-mediated regulation of inflammatory responses by actin polymerization.DNA-dependent protein kinase-mediated phosphorylation of protein kinase B requires a specific recognition sequence in the C-terminal hydrophobic motif.Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding.Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase.PHF20 positively regulates osteoblast differentiation via increasing the expression and activation of Runx2 with enrichment of H3K4me3.Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell lineIdentification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 and their role in regulating kinase activity.Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complPKB/Akt phosphorylation of ERRγ contributes to insulin-mediated inhibition of hepatic gluconeogenesis.Emerging roles of TRIO and F-actin-binding protein in human diseases.Anti-cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR/Src pathwayGinsenoside Rg3 upregulates myotube formation and mitochondrial function, thereby protecting myotube atrophy induced by tumor necrosis factor-alphaMyristoylated TMEM39AS41, a cell-permeable peptide, causes lung cancer cell death
P50
Q21136155-9610F972-E65C-4EE0-9DB8-00DDCA61303EQ24298708-4F60691C-BD22-475C-B342-E882FD44293EQ28578462-34D6181B-67D1-4792-8ED0-9E6CA15B05D1Q30876351-419CC5F6-849E-44DB-A1B6-ACB2629163B4Q33209569-9F290B69-F3AD-4D52-8BD3-E5F0EB8A34CDQ33281051-D270A9CA-A536-4BDA-B237-390DE58AD80CQ33337251-050E23A3-B78E-419F-BCC1-290442322894Q33614734-5664346A-0BA2-4D24-AABB-F72FF12DAE7FQ33716190-EE64A075-39DF-41B3-91F5-DFB4573589D6Q33744734-D8F5EFA7-2CB2-462A-8652-11F87D9357E3Q33751236-1F563AC1-48BA-4769-9B69-8D39728F4200Q34485583-24E8DF65-2E81-48A4-B535-440FD3DF5AACQ34878940-6CFB7CD7-D4D5-40FC-BAA6-FF1DC53B7108Q34990565-862A4ACB-222F-495C-8BF1-43622CB357CFQ34994043-2D7191CE-7480-4B09-83CA-5E360ADD4C9DQ36065240-B5F8F67F-6101-47EC-97FC-35C4BC8A7C15Q36987718-FFA998F3-40BC-4728-B094-6D2F4DB2E942Q37083249-F3D2151C-1E09-48EC-833C-BA0B041F00EFQ37184946-A42E4484-BB7D-4CCC-8EC4-23194596786FQ37418304-8D62C6BF-5288-4A21-9A98-0F26E35D22F2Q37440586-77FA9748-9CF9-4F82-8EC7-58702B4463E1Q37626281-2E530350-F495-41F5-9D8F-4EED6285459FQ37687063-7569683F-465E-4509-AA4F-CA0141A3E1F5Q38776581-186B17A1-786F-4E05-8EA1-D62411DEC466Q39204124-9A87EA3E-3EB2-47F8-94F5-3AE3DDEC7A9AQ39421916-3E4C90DB-1196-44CC-9D1B-955D2900DBD6Q39796892-E064A295-51F8-4675-A058-189EE022D074Q39895269-D8221E3E-7326-4C0A-BC49-6A0562E18582Q40048813-807D2128-1ACD-4CC5-860B-057539BBCBF9Q40083227-A170E8CF-957E-4BED-ACF2-48E5E5E3ABA5Q40533718-E198B423-EE20-4A23-842D-E559D3B9D262Q41388279-27F58D74-50D0-4139-99DE-36F85714A156Q42370510-FA518572-9053-40F7-9D3B-90DF5542774DQ43693180-F48802F8-576B-4471-859F-C57CDD5F0DF8Q53594418-CEBA0F1E-0D5A-4764-84DF-51E26E650F0FQ54323656-BDB9F60C-3ED4-4A67-BC9D-EE8BD3CE3A47Q55262327-839F2DD9-C348-4CA0-A497-7B89E3183CD1Q91283900-97305A36-6F4D-41FF-9860-20F486C0C881Q91608708-8AC741F6-4266-465C-92CB-ECF0EF555CEEQ91649742-1E4429F2-5C2B-4C6D-AD58-2E6E68B2DC93
P50
description
Korean pharmacologist
@en
farmacoloog uit Zuid-Korea
@nl
farmacólogu surcoreanu
@ast
name
Jongsun Park
@ast
Jongsun Park
@en
Jongsun Park
@es
Jongsun Park
@fr
Jongsun Park
@nl
type
label
Jongsun Park
@ast
Jongsun Park
@en
Jongsun Park
@es
Jongsun Park
@fr
Jongsun Park
@nl
prefLabel
Jongsun Park
@ast
Jongsun Park
@en
Jongsun Park
@es
Jongsun Park
@fr
Jongsun Park
@nl
P1053
E-7465-2010
P106
P1153
16175853100
35311723300
P1960
-qiMe50AAAAJ
P2038
Jongsun_Park3
P21
P31
P3829
P496
0000-0002-4690-1854